← Back to Markets

ACLX

Biotechnology

Who Owns This Stock

Who Owns ACLX

Other85.8%150 holders
Passive / Index15.5%10 holders
Quality / Compounder11.8%21 holders
Dealer / Bank7.5%16 holders
Tactical / Macro3.4%4 holders

Based on Q4 2025 13F filings + AC behavioral model

220 institutional holders

Top Holders

1.GILEAD SCIENCES, INC.
0.0%$438196.4B
2.Paradigm Biocapital Advisors LP
$373205.8B
3.Vanguard Group
+4.1%$243074.0B
4.NEA Management Company, LLC
$198551.1B
5.Vestal Point Capital, LP
$190710.0B
6.Fidelity Management
$168005.7B
7.SR One Capital Management, LP
0.0%$153000.3B
8.State Street
$130302.4B
9.BlackRock, Inc.
+450.4%$113683.5B
10.PERCEPTIVE ADVISORS LLC
$95587.8B
11.Citadel Advisors
+32.5%$87674.8B
12.RA CAPITAL MANAGEMENT, L.P.
$82618.6B
13.JPMORGAN CHASE & CO
$80093.3B
14.BlackRock, Inc.
+252.8%$72863.7B
15.JANUS HENDERSON GROUP PLC
-10.0%$56873.5B
16.Geode Capital Management
+2.3%$53972.8B
17.Woodline Partners LP
$48106.1B
18.Fidelity Management
+652.1%$40391.7B
19.BAMCO INC /NY/
+10.8%$39752.2B
20.Goldman Sachs AM
+40.4%$34328.5B

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Mild Selling Pressure
Other(85.8%)
Passive / Index(15.5%)
Holds
Quality / Compounder(11.8%)
Holds through
Dealer / Bank(7.5%)
Facilitating
Tactical / Macro(3.4%)
Reducing rapidly
Income / Defensive(0.3%)
Inflows (flight to yield)
Systematic / Quant(0.1%)
De-risking (mechanical)
Growth / Momentum(0.1%)
Likely trimming
Activist(0.0%)
May accumulate

27% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Market data provided by TradingView and Finnhub.